Home/Filings/4/0001093557-23-000016
4//SEC Filing

Regan Barry J. 4

Accession 0001093557-23-000016

CIK 0001093557other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:07 PM ET

Size

5.0 KB

Accession

0001093557-23-000016

Insider Transaction Report

Form 4
Period: 2023-01-30
Regan Barry J.
EVP Operations
Transactions
  • Sale

    Common Stock

    2023-01-30$106.12/sh2,213$234,84459,386 total
Footnotes (2)
  • [F1]On November 1, 2022, Mr. Regan adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Regan. The shares set forth above were sold pursuant to the 10b5-1 Plan.
  • [F2]Included in this number are 57,172 unvested restricted stock units, 19,936 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 14,136 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024.

Issuer

DEXCOM INC

CIK 0001093557

Entity typeother

Related Parties

1
  • filerCIK 0001746313

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:07 PM ET
Size
5.0 KB